Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, showing success in preclinical tests. Researchers at Uppsala University and KTH Royal Institute of Technology have developed an innovative antibody-based precision medicine with the potential to treat various types of cancer. Researchers have managed to combine three different functions […]
